Cdc7 kinase inhibitors: 5-heteroaryl-3-carboxamido-2-aryl pyrroles as potential antitumor agents. 1. Lead finding

Maria Menichincheri, Clara Albanese, Cristina Alli, Dario Ballinari, Alberto Bargiotti, Marina Caldarelli, Antonella Ciavolella, Alessandra Cirla, Maristella Colombo, Francesco Colotta, Valter Croci, Roberto Dalessio, Matteo Danello, Antonella Ermoli, Francesco Fiorentini, Barbara Forte, Arturo Galvani, Patrizia Giordano, Antonella Isacchi, Katia MartinaAntonio Molinari, Jürgen K. Moll, Alessia Montagnoli, Paolo Orsini, Fabrizio Orzi, Enrico Pesenti, Antonio Pillan, Fulvia Roletto, Alessandra Scolaro, Marco Tatò, Marcellino Tibolla, Barbara Valsasina, Mario Varasi, Paola Vianello, Daniele Volpi, Corrado Santocanale, Ermes Vanotti

Research output: Contribution to journalArticle

Abstract

Cdc7 serine/threonine kinase is a key regulator of DNA synthesis in eukaryotic organisms. Cdc7 inhibition through siRNA or prototype small molecules causes p53 independent apoptosis in tumor cells while reversibly arresting cell cycle progression in primary fibroblasts. This implies that Cdc7 kinase could be considered a potential target for anticancer therapy. We previously reported that pyrrolopyridinones (e.g., 1) are potent and selective inhibitors of Cdc7 kinase, with good cellular potency and in vitro ADME properties but with suboptimal pharmacokinetic profiles. Here we report on a new chemical class of 5-heteroaryl-3-carboxamido-2-substituted pyrroles (1A) that offers advantages of chemistry diversification and synthetic simplification. This work led to the identification of compound 18, with biochemical data and ADME profile similar to those of compound 1 but characterized by superior efficacy in an in vivo model. Derivative 18 represents a new lead compound worthy of further investigation toward the ultimate goal of identifying a clinical candidate.

Original languageEnglish
Pages (from-to)7296-7315
Number of pages20
JournalJournal of Medicinal Chemistry
Volume53
Issue number20
DOIs
Publication statusPublished - Oct 28 2010

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery
  • Medicine(all)

Fingerprint Dive into the research topics of 'Cdc7 kinase inhibitors: 5-heteroaryl-3-carboxamido-2-aryl pyrroles as potential antitumor agents. 1. Lead finding'. Together they form a unique fingerprint.

  • Cite this

    Menichincheri, M., Albanese, C., Alli, C., Ballinari, D., Bargiotti, A., Caldarelli, M., Ciavolella, A., Cirla, A., Colombo, M., Colotta, F., Croci, V., Dalessio, R., Danello, M., Ermoli, A., Fiorentini, F., Forte, B., Galvani, A., Giordano, P., Isacchi, A., ... Vanotti, E. (2010). Cdc7 kinase inhibitors: 5-heteroaryl-3-carboxamido-2-aryl pyrroles as potential antitumor agents. 1. Lead finding. Journal of Medicinal Chemistry, 53(20), 7296-7315. https://doi.org/10.1021/jm100504d